MEDTECH DIAGNOSTICS INC
NT 10-K, 1998-12-29
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CAPITAL INCOME BUILDER INC, 485BPOS, 1998-12-29
Next: SANTA FE GAMING CORP, 10-K405, 1998-12-29




                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25                      33-131110-NY
                                                                 ---------------
                                                                 SEC FILE NUMBER
                           NOTIFICATION OF LATE FILING

(Check One): |X| Form 10-K and Form 10-KSB  |_| Form 20-F  |_| Form 11-K  
             |_| Form 10-Q and Form 10-QSB  |_| Form N-SAR

             For Period Ended: September 30, 1998
                               ------------------
             |_| Transition Report on Form 10-K
             |_| Transition Report on Form 20-F 
             |_| Transition Report on Form 11-K 
             |_| Transition Report on Form 10-Q 
             |_| Transition Report on Form N-SAR 
             For the Transition Period Ended:___________________________________

- --------------------------------------------------------------------------------

  Read Attached Instruction Sheet Before Preparing form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.

- --------------------------------------------------------------------------------

If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:

- --------------------------------------------------------------------------------

PART I - Registrant Information

      Medtech Diagnostics, Inc.
- --------------------------------------------------------------------------------
Full Name of Registrant

- --------------------------------------------------------------------------------
Former Name if Applicable

      16 East 52nd Street, Suite 501
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

      New York, NY  10022
- --------------------------------------------------------------------------------
City, State and Zip Code

PART II - Rules 12b-25(b) and (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

            (a)   The reasons described in reasonable detail in Part III of this
                  form could not be eliminated without unreasonable effort or
                  expense;
            (b)   The subject annual report, semi-annual report, transition
  |X|             report on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion
                  thereof, will be filed on or before the fifteenth calendar day
                  following the prescribed due date; or the subject quarterly
                  report of transition report on Form 10-Q, or portion thereof
                  will be filed on or before the fifth calendar day following
                  the prescribed due date; and
            (c)   The accountant's statement or other exhibit required by Rule
                  12b-25(c) has been attached if applicable.

<PAGE>

PART III - NARRATIVE

State below in reasonable detail the reasons why the Form 10-K and Form 10-KSB,
11-K, 10-Q and Form 10-QSB, N-SAR, or the transition report or portion thereof,
could not be filed within the prescribed time period. (Attach Extra Sheets if
Needed)

<PAGE>

      Due to a recent change of the Registrant's bookkeeper, the Registrant's
      Form 10-KSB for the fiscal year ended September 30, 1998 could not be
      completed within the prescribed time period without unreasonable expense
      and effort.

PART IV - OTHER INFORMATION

(1)   Name and telephone number of person to contact in regard to this
      notification

      Steven N. Bronson                         (212)              872-1623
      ------------------------------------ --------------- ---------------------
          (Name)                             (Area Code)      (Telephone Number)

(2)   Have all other periodic reports required under Section 13 or 15(d) of the
      Securities Exchange Act of 1934 or Section 30 of the Investment Company
      Act of 1940 during the preceding 12 months or for such shorter period that
      the registrant was required to file such reports been filed? If answer is
      no, identify report(s).

                                                                 |X| Yes  |_| No
      --------------------------------------------------------------------------

(3)   Is it anticipated that any significant change in results of operations
      from the corresponding period for the last fiscal year will be reflected
      by the earnings statements to be included in the subject report or portion
      thereof?
                                                                 |_| Yes  |X| No


      If so, attach an explanation of the anticipated change, both narratively
      and quantitatively, and, if appropriate, state the reasons why a
      reasonable estimate of the results cannot be made.

- --------------------------------------------------------------------------------

                            MEDTECH DIAGNOSTICS, INC.
           ----------------------------------------------------------
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.


Date  December 29, 1998                       By: /s/ STEVEN N. BRONSON
      ------------------------                    ---------------------------
                                                  Steven N. Bronson, President

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

- --------------------------------------------------------------------------------

                                    ATTENTION
   Intentional misstatements or omissions of fact constitute Federal Criminal
                        Violations (See 18 U.S.C. 1001).

- --------------------------------------------------------------------------------

                              GENERAL INSTRUCTIONS

1.    This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General
      Rules and Regulations under the Securities Exchange Act of 1934.

2.    One signed original and four conformed copies of this form and amendments
      thereto must be completed and filed with the Securities and Exchange
      Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
      General Rules and Regulations under the Act. The information contained in
      or filed with the form will be made a matter of public record in the
      Commission files.

<PAGE>

3.    A manually signed copy of the form and amendments thereto shall be filed
      with each national securities exchange on which any class of securities of
      the registrant is registered.

4.    Amendments to the notifications must also be filed on form 12b-25 but need
      not restate information that has been correctly furnished. The form shall
      be clearly identified as an amended notification.

5.    Electronic Filers. This form shall not be used by electronic filers unable
      to timely file a report solely due to electronic difficulties. Filers
      unable to submit a report within the time period prescribed due to
      difficulties in electronic filing should comply with either Rule 201 or
      Rule 202 of Regulation S-T (ss.232.201 or ss.232.202 of this chapter) or
      apply for an adjustment in filing date pursuant to Rule 13(b) of
      Regulation S-T (ss.232.13(b) of this chapter).



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission